BioLineRx Market Cap

BioLineRx has a market cap or net worth of 39.16 million as of March 9, 2026. Its market cap has decreased by -16.47% in one year.

Market Cap

39.16M

Enterprise Value

-6.64M

Revenue

42.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.40

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 39.16M, an increase of 23,922.21%. That is a compound annual growth rate of 33.30%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	39.16M	-6.25%
Dec 31, 2025	41.77M	-51.17%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Clal Biotechnology Industries	46.43M
BioLight Life Sciences	31.31M
Evogene	21.42M
XTL Biopharmaceuticals	19.87M
Can-Fite BioPharma	19.70M
Purple Biotech	18.58M
Matricelf	146.87M
Geffen Residence & Renewal	277.04M

Market Cap Rankings